Information Exchange and Data Transformation (INFORMED), a multidisciplinary initiative anchored in the FDA Oncology Center of Excellence, is a decentralized science and technology incubator designed to harness the power of big data and advanced analytics to improve disease outcomes.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Translational precision medicine: an industry perspective
Journal of Translational Medicine Open Access 05 June 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Khozin, S. Kim, G. & Pazdur, R. From big data to smart data: FDA's INFORMED initiative. Nat. Rev. Drug Discov. 16, 306 (2017).
Greene, J. A. & Loscalzo, J. Putting the patient back together — social medicine, network medicine, and the limits of reductionism. N. Engl. J. Med. 377, 2493–2499 (2017)10.1056/NEJMms1706744.
Bertagnolli, M. M. et al. Advantages of a truly open-access data-sharing model. N. Engl. J. Med. 376, 1178–1181 (2017)10.1056/NEJMsb1702054.
Khozin, S. et al. Evaluating the potential for digital submission of expedited premarket safety reports to the FDA. Nat. Rev. Drug Discov. 15, 670–671 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary information
Traditional versus systems view of drug development (PDF 249 kb)
Related links
Rights and permissions
About this article
Cite this article
Khozin, S., Pazdur, R. & Shah, A. INFORMED: an incubator at the US FDA for driving innovations in data science and agile technology. Nat Rev Drug Discov 17, 529–530 (2018). https://doi.org/10.1038/nrd.2018.34
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2018.34
This article is cited by
-
Translational precision medicine: an industry perspective
Journal of Translational Medicine (2021)
-
A call for a global ‘bigger’ data approach to Alzheimer disease
Nature Reviews Drug Discovery (2019)